Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-22 | Dr. Cannon brings to our Board extensive experience in pharmaceutical company operations as well as market access expertise and a focus on data driven innovation. |
| 2022-04-25 | Dr. Cannon brings to our Board extensive experience in pharmaceutical company operations as well as market access expertise and a focus on data driven innovation. |
| 2023-04-14 | Dr. Cannon brings to Corcept more than 30 years of experience in the pharmaceutical industry, where she has served in leadership roles at Merck and Co. Inc., UCB Inc. and Otsuka Pharmaceuticals. She currently serves on the Strategic Advisory Board for Lumanity, a health consulting company. |
| 2024-04-10 | Dr. Cannon received her B.S. in Biochemistry from the University of Edinburgh, a M.B.A. from St. Joseph’s University and a Ph.D. in Health Administration from Temple University. She brings to our Board extensive experience in pharmaceutical company operations as well as market access expertise and a focus on data driven innovation. |
Data sourced from SEC filings. Last updated: 2026-02-03